Highlights of the San Antonio Breast Cancer Symposium 2020: Part 2

John R. Benson; Dorin Dumitru; Ismail Jatoi

doi:10.2217/fon-2021-0333

Highlights of the San Antonio Breast Cancer Symposium 2020: Part 2

John R. Benson, Dorin Dumitru, Ismail Jatoi

Producción científica: Article › revisión exhaustiva

Idioma original	English (US)
Páginas (desde-hasta)	2699-2703
Número de páginas	5
Publicación	Future Oncology
Volumen	17
N.º	21
DOI	https://doi.org/10.2217/fon-2021-0333
Estado	Published - jul 2021

ASJC Scopus subject areas

Oncology
Cancer Research

Acceder al documento

10.2217/fon-2021-0333

Otros archivos y enlaces

Citar esto

@article{e8d33a39e1b44810803d4db8e2567e86,

title = "Highlights of the San Antonio Breast Cancer Symposium 2020: Part 2",

keywords = "CDK 4/6 inhibitors, HER2 positive, Immunotherapy, San Antonio, drug conjugates, metastatic, multigene assays, triple-negative breast cancer",

author = "Benson, {John R.} and Dorin Dumitru and Ismail Jatoi",

year = "2021",

month = jul,

doi = "10.2217/fon-2021-0333",

language = "English (US)",

volume = "17",

pages = "2699--2703",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Taylor and Francis Ltd.",

number = "21",

}

TY - JOUR

T1 - Highlights of the San Antonio Breast Cancer Symposium 2020

T2 - Part 2

AU - Benson, John R.

AU - Dumitru, Dorin

AU - Jatoi, Ismail

PY - 2021/7

Y1 - 2021/7

KW - CDK 4/6 inhibitors

KW - HER2 positive

KW - Immunotherapy

KW - San Antonio

KW - drug conjugates

KW - metastatic

KW - multigene assays

KW - triple-negative breast cancer

UR - http://www.scopus.com/inward/record.url?scp=85108104763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108104763&partnerID=8YFLogxK

U2 - 10.2217/fon-2021-0333

DO - 10.2217/fon-2021-0333

M3 - Article

C2 - 34058844

AN - SCOPUS:85108104763

SN - 1479-6694

VL - 17

SP - 2699

EP - 2703

JO - Future Oncology

JF - Future Oncology

IS - 21

ER -